Braal, C. Louwrens http://orcid.org/0000-0003-3600-9851
Jager, Agnes
Hoop, Esther Oomen-de
Westenberg, Justin D.
Lommen, Koen M. W. T.
de Bruijn, Peter
Vastbinder, Mijntje B.
van Rossum-Schornagel, Quirine C.
Thijs-Visser, Martine F.
van Alphen, Robbert J.
Struik, Liesbeth E. M.
Zuetenhorst, Hanneke J. M.
Mathijssen, Ron H. J.
Koolen, Stijn L. W.
Funding for this research was provided by:
Erasmus Universiteit Rotterdam (Erasmus MC, the Netherlands (grant number 2017-17108)
Article History
Accepted: 19 September 2021
First Online: 17 November 2021
Declarations
:
: This work was supported by an unrestricted MRACE grant (Erasmus MC, The Netherlands; Grant number 2017-17108).
: C. Louwrens Braal, Agnes Jager, Esther Oomen–de Hoop, Justin D. Westenberg, Koen M.W.T. Lommen, Peter de Bruijn, Mijntje M. Vastbinder, Quirine C. van Rossum–Schornagel, Martine F. Thijs–Visser, Robbert J. van Alphen, Liesbeth E.M. Struik, Hanneke J.M. Zuetenhorst, Ron H.J. Mathijssen, and Stijn L.W. Koolen have no potential conflicts of interest that might be relevant to the contents of this manuscript.
: The prospective clinical study was approved by the local ethics committee (Erasmus MC, Rotterdam; MEC 17-548) and was registered in the Dutch Trial Registry (NL6918).
: Written informed consent was obtained from all patients participating in the TOTAM study.
: Available upon reasonable request.
: All authors participated in data analysis and interpretation and the writing and editing of the manuscript. Creation of figures and tables: LB, AJ, RM, and SK.